Virax Biolabs Reports Positive Early Clinical Data for ViraxImmune™ in Long COVID and Related Post-Acute Infection Syndromes

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/24/2026

1. GOOGL
2. TSLA
3. AMD
4. INTC
5. TXN
6. NOW
7. GOOG
8. CSX
9. ACI
10. KNX

Go back to Virax Biolabs Reports Positive Early Clinical Data for ViraxImmune™ in Long COVID and Related Post-Acute Infection Syndromes
(NASDAQ: VRAX) Delayed: 3.19 --0 (-0%)
Previous Close $3.19    52 Week High $ 
Open $3.19    52 Week Low $ 
Day High $3.19    P/E N/A 
Day Low $3.19    EPS $ 
Volume 426